GSK 214760 Patient
1+
Yuklanmalar
Hamma uchun
info
Bu ilova haqida
This app has been created exclusively for participants in the medical study for GSK 214760 only. It contains Televisit functionality and allows participants to complete questionnaires.
Four-part, Randomized, Double-blind (Parts 1, 2A, 3 and 4), Multi-center, Placebo-controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK3965193 Monotherapy in Healthy Participants and in Participants Living with Chronic Hepatitis B Infection; and GSK3965193 in Combination with Bepirovirsen in Participants Living with Chronic Hepatitis B Infection.
Four-part, Randomized, Double-blind (Parts 1, 2A, 3 and 4), Multi-center, Placebo-controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK3965193 Monotherapy in Healthy Participants and in Participants Living with Chronic Hepatitis B Infection; and GSK3965193 in Combination with Bepirovirsen in Participants Living with Chronic Hepatitis B Infection.
Oxirgi yangilanish
Xavfsizlik — dastur ishlab chiquvchilar maʼlumotlaringizni qanday jamlashi va ulashishini tushunishdan boshlanadi. Maʼlumotlar maxfiyligi va xavfsizlik amaliyotlari ilovadan foydalanish, hudud va yoshga qarab farq qilishi mumkin. Bu axborot dastur ishlab chiquvchi tomonidan taqdim etilgan va keyinchalik yangilanishi mumkin.
Tashqi hamkorlarga hech qanday axborot ulashilmagan
Dastur ishlab chiquvchilar axborot ulashilishini qanday aytishi haqida batafsil
Hech qanday maʼlumot jamlanmagan
Dastur ishlab chiquvchilar axborot jamlanishini qanday aytishi haqida batafsil
Maʼlumotlar uzatish vaqtida shifrlanadi
Maʼlumotlar oʻchmaydi
Nima yangiliklar
Bug fixes and performance improvements
Ilova yuzasidan yordam
Dasturchi haqida
Medable Inc.
tim@medable.com
525 University Ave Ste A70
Palo Alto, CA 94301
United States
+1 650-231-5478
